A novel ATX inhibitor with dual action
for
the treatment
of IPF:
V. Aidinis
SRC-mediated and TKS5-enabled podosome
formation is an inherent property of IPF fibroblasts, promoting
ECM
invasion and pulmonary fibrosis:
H. Barbagianni - V. Aidinis
Circadian rhythm and Pulmonary Fibrosis:
novel insights: E. Tsitoura
The role of necroptosis in A549 cells
transfected with surfactant A1 mutations: I.
Tomos
How research ideas translate to
treatments
of fibrotic lung diseases:
L. Wollin
Insomnia in Respiratory Diseases: is it worth it to be
evaluated?: M. Basta
Sleep breathing Diseases in Obstructive & Restrictive
Diseases: C. Mermigkis
New metrics in OSA severity classification: E. Kondili
Satellite Symposium ASTRAZENECA
Chair: Nikolaos Tzanakis
Stylianos Vittorakis
Important outcomes of Budesonide/glycopyrronium/
formoterol triple therapy for improving COPD management
Chair: Theodoros Vasilakopoulos
Sofia Schiza
Satellite Symposium CHIESI
Αποφρακτικά νοσήματα: εστιάζοντας στον ασθενή
Συντονιστής/Πρόεδρος: Πέτρος Μπακάκος
ΧΑΠ και συνοδά καρδιαγγειακά νοσήματα αλλάζει η
θεραπεία; Γεώργιος Χειλάς
Εξελίξεις στους συνδυασμούς σταθερής δόσης ευελιξία στη
θεραπεία του άσθματος:
Αθηνά Γόγαλη
Special Lecture
Chairs: N. Tzanakis, E. Kosmas
Challenges around inhalation therapy in asthma and COPD:
N. Roche
Asthma: From pathogenesis to treatment
Chairs: S. Loukides, P. Bakakos, G. Hillas
The effect of allergic rhinitis and nasal polyps on
asthma control: A. Papaioannou
Triple therapy or biologics for patients with asthma
uncontrolled on ICS/LABA: K. Kostikas
Discussants: K. Porpodis, K. Karagiannis
Satellite lecture MENARINI HELLAS
Πρόεδρος /Συντονιστής: Νικόλαος Τζανάκης
Έλεγχος του άσθματος: Εστιάζοντας στην συμμόρφωση του
ασθενή στην θεραπεία. Αικατερίνη Αντωνίου
GRAND DEBATE: Antifibrotics in all stages in SSC-ILD
Chairs: K. Antoniou, A. M. Hoffman-Vold
PRO: Oliver Distler
CON: Athol Wells
Keynote Lecture
Chairs: K. Antoniou, S. Schiza
Aspects of Quality of life in lung cancer care: ERS
Guidelines: J. Chorostowka
DAY END
SUNDAY 3 JULY 2022
Session 1: Primary Care & Respiratory Medicine
Chairs: G. Meletis, A. Damianaki, E. Ferdoutsis
Cases presentation:
N. Bizymi |
A. Matthaiou | S. Vittorakis | G. Stathakis | N. Bizymi, S. Viziriannaki | K. Symvoulaki | A. Matthaiou,
E. Vakouti, S. Vittorakis, E. Vlachaki, A. Solakis, C. Protopapadakis, M.
Varoucha, E. Argiana, G. Stathakis, S. Viziriannaki, K. Symvoulaki, A.
Matthaiou, N. Bizymi
|
Chairs:
T. Vassilakopoulos
What does RSV mean for patients with respiratory
conditions: the role of the Pulmonologist: N. Tzanakis
ILAs: Red flags in ILDs:
S. Tomassetti
Chairs:
K. Antoniou, A. M. Hoffmann-Vold
IPAF? Is it a Clinical Diagnosis? PRO :
S. Tomassetti
CON : A. Wells
Special Lecture:
Chairs: A. Wells
Lymphoproliferative diseases of the Lung: V. Poletti
Session 2: Novel insights in ILDs
Chairs: A. Wells, K. Antoniou
CTD-ILD and the ERS-EULAR Guidelines:
O. Distler |
EULAR and Respiratory Medicine:novel insights:
A.M. Hoffmann-Vold |